Resultado de búsqueda
As of 2019, the AACE lists GLP-1 agonists, along with SGLT2 inhibitors, as the most preferred anti-diabetic agents after metformin. Liraglutide in particular may be considered first-line in diabetic patients with cardiovascular disease, as it has received FDA approval for reduction of risk of major adverse cardiovascular events in ...
There are a number of different classes of anti-diabetic medications. Type 1 diabetes requires treatment with insulin, ideally using a "basal bolus" regimen that most closely matches normal insulin release: long-acting insulin for the basal rate and short-acting insulin with meals.
- Insulin insufficiency or gradual resistance
- 4.2 million (2019)
Alpha-glucosidase inhibitors ( AGIs) are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates (such as starch and table sugar ).
Abstract. Diabetes mellitus (DM) is one of the most prevalent chronic diseases and has been a leading cause of death in the last decades. Thus, methods to detect, prevent or delay this disease and its co-morbidities have long been a matter of discussion.
- Maria J. Meneses, Branca M. Silva, Mário Sousa, Rosália Sá, Pedro F. Oliveira, Marco G. Alves
- 2015
Un antidiabético es un medicamento usado para reducir los niveles de glucosa en sangre, por lo que se indica en el tratamiento de la diabetes mellitus. Con la excepción de la insulina, exenatida, liraglutida, lixisenatida y dulaglutida, todos son administrados por vía oral.
Category:Anti-diabetic drugs - Wikipedia. This category reflects the organization of Anatomical Therapeutic Chemical Classification System code A10. Generally, drugs outlined within the ATC code A10 should be included in this category. WP:PHARM:CAT for more information. Wikimedia Commons has media related to Anti-diabetic drugs.
19 de feb. de 2021 · Three of these are the newer antidiabetic drug classes: sodium-glucose cotransporter-2 inhibitors (SGLT2i), dipeptidyl peptidase-4 inhibitors (DPP-IVi), and glucagon-like peptide-1 receptor agonists (GLP-1RA) [ ]. Precision medicine is a newer therapeutic concept which strives to distinguish patients based on their treatment response [ ].
